These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 19074077)
21. New insights into the pathophysiology and development of novel therapies for sickle cell disease. Moerdler S; Manwani D Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):493-506. PubMed ID: 30504350 [TBL] [Abstract][Full Text] [Related]
22. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. Kaul DK; Fabry ME; Costantini F; Rubin EM; Nagel RL J Clin Invest; 1995 Dec; 96(6):2845-53. PubMed ID: 8675655 [TBL] [Abstract][Full Text] [Related]
23. [Pathophysiology of sickle cell disease]. Elion J; Laurance S; Lapouméroulie C Med Trop (Mars); 2010 Dec; 70(5-6):454-8. PubMed ID: 21520646 [TBL] [Abstract][Full Text] [Related]
24. [Physiological and pathological features of the red blood cells and the hemoglobin as a principle for disease manifestations]. BETKE K Dtsch Med Wochenschr; 1962 May; 87():909-14. PubMed ID: 13868622 [No Abstract] [Full Text] [Related]
25. Blockade of adhesion of sickle cells to endothelium by monoclonal antibodies. Hebbel RP N Engl J Med; 2000 Jun; 342(25):1910-2. PubMed ID: 10861330 [No Abstract] [Full Text] [Related]
27. Therapeutic strategies in Sickle Cell Anemia: The past present and future. Fernandes Q Life Sci; 2017 Jun; 178():100-108. PubMed ID: 28435037 [TBL] [Abstract][Full Text] [Related]
28. [Erythrocyte adhesion to vascular endothelium: clinical applications]. Chaudet B; Renard M; Seigneur M; Boisseau MR Rev Med Interne; 2000 Jul; 21(7):599-607. PubMed ID: 10942976 [TBL] [Abstract][Full Text] [Related]
29. Non-uniformity of intracellular polymer formation in sickle erythrocytes: possible correlation with severity of hemolytic anemia. Noguchi CT; Schechter AN Am J Pediatr Hematol Oncol; 1984; 6(1):46-50. PubMed ID: 6711762 [TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 effects on oxygen affinity by sickle erythrocytes. Rabinowitz I; Wolf PL; Shikuma N; Berman S Prostaglandins; 1974 Aug; 7(4):309-17. PubMed ID: 4415346 [No Abstract] [Full Text] [Related]
31. A further note on red cell discoveries. William B. Castle's contribution to the discovery of hemoglobin S. Brecher G Blood Cells; 1982; 8(2):471-2. PubMed ID: 6760931 [No Abstract] [Full Text] [Related]
37. Adhesion of sickle red cells to endothelium: myths and future directions. Hebbel RP Transfus Clin Biol; 2008; 15(1-2):14-8. PubMed ID: 18501652 [TBL] [Abstract][Full Text] [Related]
38. Influence of sickle hemoglobin polymerization and membrane properties on deformability of sickle erythrocytes in the microcirculation. Dong C; Chadwick RS; Schechter AN Biophys J; 1992 Sep; 63(3):774-83. PubMed ID: 1420913 [TBL] [Abstract][Full Text] [Related]
39. Physico-chemical mechanisms in the pathogenesis of certain hemolytic anemias. SHARPSTEEN JR Am J Med Sci; 1955 May; 229(5):506-16. PubMed ID: 14361417 [No Abstract] [Full Text] [Related]
40. The background of our knowledge of the mutant hemoglobins. Schroeder WA Tex Rep Biol Med; 1980-1981; 40():137-42. PubMed ID: 7034265 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]